Pharmacodynamics of trovafloxacin in experimental pneumococcal meningitis: Basis for dosage selection in children with meningitis

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 5, 1999, Pages 683-688

  McCoig, Cynthia C ^a   Wubbel, Loretta ^a   Jafri, Hasan S ^a   Lutsar, Irja ^a   Bastero, Rafael ^a   Olsen, Kurt ^a   Shelton, Sharon ^a   Friedland, Ian R ^a   McCracken, George H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALATROFLOXACIN; BETA LACTAM ANTIBIOTIC; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROVAFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL MENINGITIS; BACTERICIDAL ACTIVITY; CEREBROSPINAL FLUID LEVEL; CORRELATION FUNCTION; DRUG PENETRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARMACODYNAMICS; RABBIT; STREPTOCOCCUS INFECTION;

ANIMALS; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; CEREBROSPINAL FLUID; DISEASE MODELS, ANIMAL; FLUOROQUINOLONES; HALF-LIFE; HUMANS; INFANT; MALE; MENINGITIS, PNEUMOCOCCAL; MICROBIAL SENSITIVITY TESTS; NAPHTHYRIDINES; PENICILLIN RESISTANCE; RABBITS; STREPTOCOCCUS PNEUMONIAE;

EID: 0032942593     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.5.683     Document Type: Article

References (16)

1. Gump, D. W. (1981). Vancomycin for treatment of bacterial meningitis. Reviews of Infectious Diseases 3, Suppl., S289-92.
2. Paris, M. M., Hickey, S. M., Uscher, M. I., Shelton, S., Olsen, K. D. & McCracken, G. H., Jr. (1994). Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrobial Agents and Chemotherapy 38, 1320-4.
3. Ooie, T., Suzuki, H., Terasaki, T. & Sugiyama, Y. (1996). Comparative distribution of quinolone antibiotics in cerebrospinal fluid and brain in rats and dogs. Journal of Pharmacology and Experimental Therapeutics 278, 590-6.
4. Scheld, W. M. (1989). Quinolone therapy for infections of the central nervous system. Reviews of Infectious Diseases 11, Suppl. 5, S1194-202.
5. Craig, W. A. (1998). Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clinical Infectious Diseases 26, 1-12.
6. Kim, Y. S., Liu, Q., Chow, L L. & Täuber, M. G. (1997). Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 41, 1186-9.
7. Friedland, I. R., Shelton S., Paris, M., Rinderknecht, S., Ehrett, S., Krischer, K. et al. (1993). Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatric Infectious Disease Journal 12, 196-200.
8. National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard M7-A3. NCCLS, Villanova, PA.
9. Dacey, R. G. & Sande, M. A. (1974). Effect of probenecid on cerebrospinal fluid concentration of penicillin and cephalosporin derivatives. Antimicrobial Agents and Chemotherapy 6, 437-41.
10. Paris, M. M., Hickey, S. M., Trujillo, M., Shelton, S. & McCracken, G. H., Jr. (1995). Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrobial Agents and Chemotherapy 39, 1243-6.
11. Simon, H. J. & Yin, E. J. (1970). Microbioassay of antimicrobial agents. Applied Microbiology 19, 573-9.
12. Ebert, S. C. & Craig, W. A. (1990). Pharmacodynamic properties of antibiotics: application to drug monitoring and dosage regimen design. Infection Control and Hospital Epidemiology 11, 319-26.
13. Vogelman, B. & Craig, W. A. (1986). Kinetics of antimicrobial activity. Journal of Pediatrics 108, 835-40.
14. Drusano, G. L., Johnson, D. E., Rosen, M. & Standiford, H. C. (1993). Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrobial Agents and Chemotherapy 37, 483-90.
15. Forrest, A., Nix, D. E., Ballow, C. H., Goss, T. F., Birmingham, M. C. & Schentag, J. J. (1993). Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrobial Agents and Chemotherapy 37, 1073-81.
16. Arguedas-Mohs, A., Vargas, S. L., Bradley, J. S., Loaiza, C., Rivera, R., Vincent, J. et al. (1997). Trovafloxacin CSF penetration and pharmacokinetics in children. In Abstracts of the Thirty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 1997. Abstract A-105, p. 21. American Society for Microbiology, Washington, DC.